Short description
CiRC Biosciences is a biotech company developing potential cell therapy treatments for vision loss conditions.
Description
CiRC Biosciences operates in the biotechnology industry, focusing on the development of potential cell therapy treatments. The company is currently in the pre-clinical development stage for a treatment for retinitis pigmentosa (RP) and dry age-related macular degeneration. These conditions are related to vision loss, and CiRC Biosciences is working on innovative solutions to address them. The company is a portfolio company of Paragon Biosciences.
Total funding
$$43214321
Sign in for full access
Location
Chicago, Illinois, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Founders
Sai Chavala